Arvinas Stock News & Updates

[WKN: A2N6VP | Symbol: ARVN]
Arvinas

Arvinas (ARVN) in our Pivotal Point Check: Groundbreaking PROTAC Drugs and Analyst Upgrade Drive the Biotech Company up Over 20% after Quarterly Results!

Arvinas: Barclays Sees 110% Price Potential - Experts see Multiple Opportunities in Oncology and Neurology

Arvinas Inc. (ARVN) is a biotechnology company developing a unique technology called PROTACs (PROteolysis...

  • ‹
  • 1
  • ›